Postdoctoral or scientist positions for neural repair and neuroscience study

Postdoctoral or scientist positions are available to study exciting projects supported by NIH and other research foundations in the Shriners Hospitals Pediatric Research Center at Temple University in Philadelphia. These positions provide a unique opportunity to participate in a collaborative environment to perform comprehensive research toward understanding the cellular and molecular mechanisms of neural damage and developing therapeutic strategies for neurological disorders.

Highly motivated individuals with a strong background in the below areas are encouraged to apply: 1) viral vector and genetic research approaches, 2) in vivo animal models to study neural injury and repair/regeneration, and 3) molecular/cellular neurobiology and biochemistry. Candidates should have a PhD, MD/PhD, or equivalent in the field of neuroscience, molecular/cellular biology, biomedicine, or biochemistry. Following appropriate training, the successful applicants will have ample opportunity to develop new research skills and to perform innovative and cutting-edge funded research projects. The research in our Center is focused on neural repair and regeneration and the Center provides outstanding research facilities and environment for all trainees and scientists. Successful applicants will be paid with NIH/University guideline-based salary plus the standard benefits and become members of a high-motivated research team in collaboration with other excellent research groups.

The research projects in our group focus on studying neural damages, neuronal regeneration, astrocytic scar formation, and remyelination in the CNS. We are investigating the molecular/cellular mechanisms underlying neuronal damage, regrowth failure, and demyelination in the CNS, and developing novel and highly effective strategies to promote neuronal regeneration, repair, and functional recovery. We are highly interested in identifying novel genes and signaling pathways that regulate neural function and regrowth using various molecular, transgenic, and viral approaches. We employ combined in vitro and in vivo research approaches, including viral gene delivery, genetic and pharmacological methods, molecular/cellular neurobiology, gene sequencing, biochemistry, and multiple neural/axonal lesion models (such as spinal cord injury, optic nerve crush, and experimental autoimmune encephalomyelitis) in rodents.

You are encouraged to find further information on our research program by visiting: https://www.ncbi.nlm.nih.gov/myncbi/1hqX7tzAf8ekp/bibliography/public/, and https://medicine.temple.edu/shuxin-li.  You are encouraged to read our example publications: Mol Ther. 2020 Aug 5;28(8):1902-1917; Nat Commun. 2021 Jun 22;12(1):3845; Cell Metab. 2020 Nov 3;32(5):767-785.e7; Mol Ther. 2019 Jan 2;27(1):102-117; Brain Behav Immun. 2017 Oct;65:111-124; J Clin Invest. 2016 Jun 1;126(6):2321-33; Nature. 2015 Feb 19;518(7539):404-8; Biomaterials. 2014 May;35(16):4610-26; Neuron. 2003 Apr 24;38(2):187-99; and Nature. 2002 May 30;417(6888):547-51.

Temple University is exceedingly diverse in all aspects of university life and is an Equal Opportunity/Affirmative Action Employer. Please send curriculum vitae or inquiry to Dr. Shuxin Li (Shuxin.li@temple.edu).